Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
Nordberg
Agneta
A
Neurotec Department, Karolinska Institutet, Karolinska University Hospital Huddinge B84, 141 86 Stockholm, Sweden. agneta.nordberg@neurotec.ki.se
D000544:Alzheimer Disease / Q000000981:diagnostic imaging* / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D058225:Plaque, Amyloid / Q000000981:diagnostic imaging*; D011379:Prognosis; D011877:Radionuclide Imaging
D016229:Amyloid beta-Peptides; D015415:Biomarkers